Ezra, the healthcare AI startup, has raised $21 million in a Series B funding round to expand its innovative full-body MRI cancer screening services across the United States. The new funding brings Ezra’s total financing to $41 million and is aimed at accelerating the company’s growth and technological advancements.
Expansion and Technological Advancements
Ezra plans to use the new capital to expand its presence to 50 new locations across 20 cities in North America. This expansion will enable the company to make its AI-powered full-body MRI scans more accessible to a larger population. By leveraging advanced AI technologies, Ezra aims to reduce the time and cost of MRI scans significantly, making early cancer detection more affordable and accessible.
The company’s AI innovations, which include the FDA-cleared Ezra Flash AI, have enabled it to offer a 30-minute full-body MRI scan for $1,350. Ezra is also working on developing a 15-minute full-body MRI scan priced at around $500, expected to launch within the next two to three years. These advancements represent a significant leap in making comprehensive cancer screening more accessible to the general public.
Strategic Partnerships
In April 2024, Ezra announced a strategic partnership with RAYUS Radiology, a leading provider of imaging services in the United States. This partnership will enable Ezra to expand its services to 150 RAYUS locations nationwide. The collaboration aims to integrate Ezra’s AI technology into RAYUS’s imaging facilities, providing advanced early cancer detection and monitoring for over 500 conditions across up to 13 organs. This partnership aligns with Ezra’s mission to make early cancer detection more widespread and accessible.
Pioneering AI in Cancer Screening
Ezra distinguishes itself by utilizing AI across all key components of the cancer screening process: imaging, analysis, and reporting. The company’s AI tools, such as Ezra Prostate AI and Ezra Reporter AI, assist radiologists in analyzing MRI images and generating comprehensive reports that are easy for medical professionals to interpret. This integrated approach helps minimize overdiagnosis and false positives, addressing some of the common concerns associated with full-body MRI scans.
Market Impact and Future Goals
Founded in 2018 by Emi Gal, Ezra has already scanned thousands of individuals, helping detect cancer and other diseases at early stages. The company’s services are available at various price points, from $950 to $2,500, depending on the type of scan and additional features like low-dose chest CT scans for lung cancer screening and coronary calcium scoring for heart health analysis. Ezra’s direct-to-consumer business model, which includes payment options through HSA/FSA dollars and monthly installment plans, makes its services more accessible to a broader audience.
Ezra’s vision is to screen everyone in the world for cancer, targeting the vast healthcare market. The company aims to create a new standard for preventive care, advocating for annual health screenings that can detect cancer and other conditions early. With the support of significant investors like Healthier Capital, FirstMark Capital, and Allianz Life Ventures, Ezra is well-positioned to achieve its ambitious goals and continue its rapid growth trajectory.
References & Further Reading
- ezra.com. (2024, February 8). Retrieved from Ezra, an Innovator in Applying AI to MRI Scanning, Raises $21M to Increase Access to Care
- radiologybusiness.com. (2024, February 9). Retrieved from Whole-body MRI startup Ezra raises $21M, eyes 50 new locations in 2024
- alleywatch.com. (2024, February 8). Retrieved from Ezra Raises Another $21M for Full Body MRIs Powered by AI That Makes Early Detection Possible for Cancer and 500 Other Types of Diseases
- globenewswire.com. (2024, April 15). Retrieved from Ezra, AI Leader in the Full Body MRI Space, Announces Partnership with Imaging Leader RAYUS Radiology
- news.ucwe.com. (2024, April 15). Retrieved from Rayus Radiology Partners with Ezra to Launch Nationwide Whole Body MRI Offering